BRIEF-Cipher Pharmaceuticals announces approvals of SD Cream and AD Cream
April 6 (Reuters) - Cipher Pharmaceuticals Inc
* Cipher Pharmaceuticals announces approvals of astion acquired barrier creams by Health Canada and the Medicines Evaluation Board
* Says in addition European approval of helioclin pruritus SD cream (also known as pruridexin) was achieved
* In Canada , Cipher plans to market products through its internal sales team
* Says company expects to out-license helioclin pruritus sd cream and helioclin dermatitis SD cream in Europe Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.